President Trump on Friday slammed what he described as “treasonous” media coverage of the U.S. conflict with Iran, accusing New York Times reporter David Sanger of misrepresenting the military ...
More access to affordable weight-loss medications is coming this summer for adults on Medicare. Starting in July, certain Medicare enrollees can pay $50 a month for specific prescription GLP1 ...
Amazon One Medical has launched a GLP-1 management program that integrates primary care, pharmacy services and virtual care options to simplify the patient experience. The program aims to address ...
The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from insurers. The Centers for Medicare & Medicaid Services first announced the ...
WASHINGTON — The U.S. Space Force selected 14 companies to compete for contracts under a new $1.8 billion procurement of satellites and supporting technologies to monitor activity in geosynchronous ...
Feeling the monetary hit from tax season? To help with additional burdens from property taxes, New Jersey offers a trio of programs to provide some relief. These programs include Affordable New Jersey ...
Adolescent and Young Adult Cancer Survivors' Perspectives About Experiences of Cancer Care in Central America, the Caribbean, Mexico, and Peru: A Qualitative Study Patient navigation programs have ...
The maker of the GLP-1 weight-loss drug Wegovy is promising “a lower, predictable monthly price” for patients who use a new subscription program for the medication. The savings add up to $600 a year ...
Even if you don’t know much about the inner workings of generative AI models, you probably know they need a lot of memory. Hence, it is currently almost impossible to buy a measly stick of RAM without ...
A home blood pressure telemonitoring program effectively reduced blood pressure in real-world clinical settings, but program enrollment expenses increased overall costs. Objectives: To evaluate the 12 ...
GLP-1 weight-loss drugs have quickly become some of the most sought-after medications in the United States, but their price tags have also made them one of the most difficult benefits for employers ...